ONHEALTH NETWORK CO
NT 10-Q, 2000-05-15
PREPACKAGED SOFTWARE
Previous: HEALTHRITE INC, 10QSB, 2000-05-15
Next: MHM SERVICES INC, 10-Q, 2000-05-15




                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 12B-25

                           NOTIFICATION OF LATE FILING

(CHECK ONE):

[ ] Form 10-K and Form 10-KSB              [ ]Form 20-F
[X] Form 10-Q and Form 10-QSB              [ ]Form N-SAR

For period ended: March 31, 2000

[ ]  Transition Report on Form 10-K
[ ]  Transition Report on Form 20-F
[ ]  Transition Report on Form 11-K
[ ]  Transition Report on Form 10-Q
[ ]  Transition Report on Form N-SAR
For the Transition Period Ended: _______________________________________

  Read Attached Instruction Sheet Before Preparing Form. Please Print or Type.

      Nothing in this Form shall be construed to imply that the Commission
                 has verified any information contained herein.

If the notification  relates to a portion of the filing checked above,  identify
the Item(s) to which the notification relates:
                                             -----------------------------------

PART I - REGISTRANT INFORMATION

Full Name of Registrant: ONHEALTH NETWORK COMPANY

Former Name if Applicable: IVI PUBLISHING, INC.

Address of Principal Executive Office (Street and Number):
     808 HOWELL STREET, SUITE 400, SEATTLE, WASHINGTON 98101

PART II - RULES 12B-25(b) AND (c)

If the subject report could not be filed without  unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)

[X]     (a) The reasons  described in reasonable detail in Part III of this form
        could not be eliminated without unreasonable effort or expense;

[X]     (b) The subject annual report,  semi-annual report, transition report on
        Form 10-K,  Form 20-F,  11-K or Form N-SAR,  or portion  thereof will be
        filed on or before the fifteenth  calendar day following the  prescribed
        due date; or the subject  quarterly report or transition  report on Form
        10-Q, or portion  thereof will be filed on or before the fifth  calendar
        day following the prescribed due date; and

[ ]     (c) The accountant's  statement  or  other  exhibit  required  by  Rule
        12b-25(c) has been attached if applicable.

PART III - NARRATIVE

State below in  reasonable  detail the  reasons  why Form 10-K and Form  10-KSB,
20-F,  11-K, 10-Q and Form 10-QSB,  N-SAR,  or the transition  report or portion
thereof could not be filed within the prescribed period.

         As  previously  disclosed,  the Company is in the process of  restating
certain  of its  historical  financial  statements  to adjust its  treatment  of
certain  employee stock option awards.  As a result,  the Company is not able to
finalize  the  financial  statements  for its most  recent  quarter  as  certain
elements  of such  financial  statements  are  impacted  by the results of these
efforts.

PART IV - OTHER INFORMATION

(1)  Name  and  telephone  number  of  person  to  contact  in  regard  to  this
notification:

    GARY J. KOCHER                (206)                  623-7580
- ------------------------   ------------------     ---------------------
      (Name)                   (Area Code)         (Telephone Number)

(2) Have all other  periodic  reports  required under Section 13 or 15(d) of the
Securities  Exchange Act of 1934 or Section 30 of the Investment  Company Act of
1940  during  the  preceding  12  months  or for such  shorter  period  that the
registrant was required to file such report(s) been filed?  If the answer is no,
identify report(s). [X] Yes [ ] No

(3) Is it anticipated that any significant  change in results of operations from
the  corresponding  period for the last  fiscal  year will be  reflected  by the
earnings statements to be included in the subject report or portion thereof?
[X] Yes [ ] No

If so, attach an explanation of the  anticipated  change,  both  narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.

The  Company  anticipates  that its  results of  operations  for the three month
period ended March 31, 2000 will reflect a  significant  change from its results
of operations  for the same period in 1999.  Net Revenue is expected to increase
significantly  over the same prior year period as a result of  increased  online
revenue as well as increased services and communication revenue generated by our
wholly-owned  subsidiary  Health  Decisions  International  ("HDI"),  which  was
acquired on November 29, 1999 and will be included in the consolidated financial
statements in 2000. The net loss is expected to increase  significantly from the
prior year period as a result of the  Company's  increased  sales and  marketing
efforts, growth in personnel, non-cash expenses related to business acquisitions
that  occurred in the third and fourth  quarters of 1999 and the addition of the
results of operations of HDI.

- --------------------------------------------------------------------------------



                            ONHEALTH NETWORK COMPANY
- --------------------------------------------------------------------------------
                  (Name of Registrant as Specified in Charter)

has  caused  this  notification  to be signed on its  behalf by the  undersigned
hereunto duly authorized.

Date: May 15, 2000                          By:  /S/ RON STEVENS
                                                --------------------------------
                                                Name:  Ron Stevens
                                                Title:   Chief Financial Officer


INSTRUCTION: The form may be signed by an executive officer of the registrant or
by any other duly  authorized  representative.  The name and title of the person
signing  the form  shall  be typed or  printed  beneath  the  signature.  If the
statement is signed on behalf of the registrant by an authorized  representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.

- ---------------------------------- ATTENTION -----------------------------------
Intentional  misstatements  or omissions  of fact  constitute  Federal  Criminal
Violations (See 18 U.S.C. 1001).
- --------------------------------------------------------------------------------



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission